MannKind Corp. (MNKD)
3.74
-0.05
(-1.32%)
USD |
NASDAQ |
Sep 11, 15:43
MannKind Gross Profit (TTM) : 284.03M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 284.03M |
| March 31, 2026 | 264.53M |
| December 31, 2025 | 257.03M |
| September 30, 2025 | 235.90M |
| June 30, 2025 | 226.02M |
| March 31, 2025 | 222.08M |
| December 31, 2024 | 208.90M |
| September 30, 2024 | 192.14M |
| June 30, 2024 | 177.08M |
| March 31, 2024 | 159.44M |
| December 31, 2023 | 136.19M |
| September 30, 2023 | 115.72M |
| June 30, 2023 | 94.09M |
| March 31, 2023 | 65.69M |
| December 31, 2022 | 42.27M |
| September 30, 2022 | 23.42M |
| June 30, 2022 | 20.38M |
| March 31, 2022 | 27.75M |
| December 31, 2021 | 36.58M |
| September 30, 2021 | 47.66M |
| June 30, 2021 | 45.52M |
| March 31, 2021 | 41.62M |
| December 31, 2020 | 40.50M |
| September 30, 2020 | 37.32M |
| June 30, 2020 | 32.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 31.88M |
| December 31, 2019 | 35.06M |
| September 30, 2019 | 36.05M |
| June 30, 2019 | 29.65M |
| March 31, 2019 | 20.41M |
| December 31, 2018 | 7.98M |
| September 30, 2018 | -2.467M |
| June 30, 2018 | -4.265M |
| March 31, 2018 | -6.486M |
| December 31, 2017 | -5.482M |
| September 30, 2017 | -4.373M |
| June 30, 2017 | 133.84M |
| March 31, 2017 | 133.06M |
| December 31, 2016 | 125.07M |
| September 30, 2016 | 72.69M |
| June 30, 2016 | -71.10M |
| March 31, 2016 | -76.73M |
| December 31, 2015 | -74.07M |
| September 30, 2015 | -33.50M |
| June 30, 2015 | -27.80M |
| March 31, 2015 | -20.92M |
| December 31, 2014 | -25.45M |
| September 30, 2014 | -18.20M |
| June 30, 2014 | -19.23M |
| March 31, 2014 | -20.10M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| United Therapeutics Corp. | 2.717B |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Gilead Sciences, Inc. | 24.33B |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Ocugen, Inc. | 2.647M |